CIK 0001810182 · Non-accelerated filer<br>Smaller reporting company
ALX ONCOLOGY HOLDINGS INC
Sign in to watch- Ticker
- ALXO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 850642577
- Phone
- 650-466-7125
- Business address
- 323 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- 4 Derivatives Options or other derivatives
- 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 92,233 shares at an average $1.08 ($99,352)
- 8-K Event Executive or director change · Other events
- 4 Open-market buy Chief Financial Officer bought 75,000 shares at $0.78 ($58,403)
- 4 Open-market sale SVP, FINANCE AND CAO sold 611 shares at $0.64 ($391)
- 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 2,382 shares at $0.64 ($1,525)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Executive or director change · Other events
- 4 Open-market sale SVP, FINANCE AND CAO sold 2,011 shares at $0.45 ($905)
- 4 Open-market sale SVP, FINANCE AND CAO sold 1,532 shares at $0.43 ($659)
- 8-K Event Shareholder vote results
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Delisting notice
- EFFECT Other Notice of Effectiveness
Page 4 of 22 · 421 filings